Cardiac electrophysiology is an evolving specialty that has seen rapid advances in recent years. Concurrently, there has been much progress in the field of cardiac imaging. Electrophysiologists are increasingly requesting cross-sectional imaging in advance of many procedures. Pulmonary vein isolation and left atrial appendage (LAA) occlusion are now an established treatment options for atrial fibrillation. In patients undergoing pulmonary vein isolation, applications of computed tomography (CT) include evaluating the left atrial and pulmonary venous anatomy, excluding LAA thrombus and assessing for pulmonary vein stenosis. In those undergoing LAA occlusion, CT may be of value in assessing the size, position, and morphology of the LAA as well as for determining correct positioning of the device and evaluating for peri-device leak. Implantable cardiac devices are now commonly used in the management of cardiac failure and cardiac arrhythmias. Applications of CT prior to device implantation include detecting myocardial scar, evaluating for mechanical dyssynchrony as well as visualising the coronary venous anatomy.
Introduction
Cardiac electrophysiology (EP) is an evolving specialty that has seen rapid advances in recent years. Radiofrequency catheter ablation (RFCA) is now a standard therapy for a growing range of atrial and ventricular arrhythmias, including atrial fibrillation (AF). In addition, implantable cardiac devices are being increasingly used in the management of congestive cardiac failure and cardiac arrhythmias.
Concurrently, there has been much progress in the field of cardiac imaging. Modern multidetector row cardiac computed tomography (CT) now provides submillimetre spatial resolution and a temporal resolution of less than 100 ms, making it ideally suited for evaluation of cardiac anatomy. Moreover, cardiac CT images can now be imported into electroanatomic mapping software and merged with information obtained during EP procedures.
Electrophysiologists are increasingly requesting cross-sectional imaging [CT or magnetic resonance imaging (MRI)] in advance of many procedures. This article will discuss value of cardiac CT in electrophysiology intervention with a particular focus on pulmonary vein isolation, left atrial appendage (LAA) occlusion, and cardiac device implantation, as well as describing how to optimize the CT protocol for each application.
Cardiac CT technique
Exact CT protocols vary depending on the scanner manufacturer. However, as an example, at our institution, images are acquired on an 80 detector row, helical CT scanner (Aquilion Prime, Toshiba Medical Systems, Japan) from the carina to the diaphragm with an inspiratory breath hold. A tube kVp of 100-135 is used depending on patient body mass index (BMI) (kVp 100 for BMI < 20; kVp 120 for BMI 20-30; kVp 135 for BMI > 30). Tube current modulation and prospective electrocardiogram (ECG) gating are employed for patients in sinus rhythm. The pitch is set at 0.6. Oral or intravenous beta-blockers are administered to achieve a heart rate of <65 bpm.
In general, 70 mL of non-ionic low-osmolar contrast medium (iopamidol, 370 mg/mL; Bracco SpA, Milan, Italy) and a 30 mL saline chaser bolus are administered at a rate of 5 mL/s. The saline chaser helps with opacification of the area of interest and also reduces artifact from the superior vena cava (SVC) and right atrium. The optimal timing of acquisition is decided in advance depending on the clinical question and required anatomic detail. A test bolus or bolus tracking method can be used to achieve opacification of the anatomic area of interest. The timing to optimal opacification can differ significantly between patients due to the differences in cardiac output, volume status, and the location of the venous access site. For this reason, a bolus tracking method is advised.
In the bolus tracking method, a region of interest (ROI) is positioned over the left atrium (LA) when assessing the LA and pulmonary veins prior to RFCA. When the coronary arteries are the primary concern, the ROI is positioned over the descending thoracic aorta. Should coronary venous anatomy be of specific interest a delayed dual acquisition may be required though this will add to radiation exposure. Typically, a 4 s delay is sufficient to allow for opacification of the coronary sinus and veins. In patients in heart failure, pre-device implantation CT may require manual triggering or a test bolus for optimal timing as bolus tracking may fail.
Patients undergoing cardiac CT often have AF and may not be in sinus rhythm at the time of scanning. Arrhythmia can lead to slice misregistration, non-diagnostic images as well as an increase in radiation dose. It is important that the radiographer/radiologist recognises the arrhythmia. In such patients, we use retrospective ECG gating with a low mAs setting to try and offset the increased radiation exposure of retrospective gating. Other techniques include the use of 320 detector row scanning with 16 cm z-axis coverage or a high-pitch dual source scanning mode, both of which can circumvent the difficulty of ECG gating in patients with AF by scanning the volume over one heart beat.
Following data acquisition, ECG gated images are reconstructed in an optimal end diastolic phase viewed on 0.5 mm contiguous slices on a 3D work station. Multiplanar reformatted images then allow for accurate measurements of the structures of interest.
The radiation dose from cardiac CT has reduced substantially in recent years, largely due to prospective ECG-gating, and is now typically in the 1-2 mSv range for CT coronary angiography performed with contemporary equipment. [1] [2] [3] In comparison, the dose from a chest X-ray is typically 0.02 mSv, whereas the exposure from invasive coronary angiography can range from 1 to 15 mSv depending on the skill of the operator and complexity of the procedure. 4 
Pulmonary vein isolation
AF is the most common cardiac arrhythmia and is associated with an increased risk of thromboembolic disease, heart failure, and all-cause mortality. 5 RFCA is an established treatment option in those who prove refractory to pharmacological therapy. It is a safe and effective treatment with 76% of patients free from AF at 5 years if redo procedures are included and a reported complication rate of 4.5%.
6,7
The goal of the ablation procedure is to electrically isolate the ectopic foci within the pulmonary veins from the body of the LA. This is achieved by accessing the LA via a transeptal approach from the right atrium and performing a circumferential ablation around the veno-atrial junction. Supplementary ablation lines may also be performed on the posterior wall and roof of the LA, in the region of the mitral valve annulus, or in the region of the coronary sinus. Table 1 outlines the applications of CT in pulmonary vein isolation. CT is valuable for evaluating the anatomy and dimensions of the LA and pulmonary veins ( Figure 1 ) and for identifying any variant anatomy that may interfere with the procedure, such as accessory pulmonary veins or shared pulmonary vein ostia (Figure 2 ). This information can CT is also of value in assessing the anatomy of the SVC and inferior vena cava; excluding the presence of thrombus in the LAA; identifying the location and course of the oesophagus; as well as identifying the fossa ovalis ( Figure 3) , and any anomalies that may interfere with transeptal puncture, such as lipomatous hypertrophy of the interatrial septum.
Pre-procedural imaging
Both CT and MRI images can be fused with electro-anatomic maps and/or overlaid onto real time fluoroscopic images ( Figure 4 ). Several studies have suggested that such fusion techniques may reduce procedure time, recurrence rates of AF, and fluoroscopic radiation exposure. 8 Such benefits however have to be weighed against the radiation associated with CT, which was traditionally reported in the range of 4.6-13.4 mSv. 9 However, levels of approximately 1 to 2 mSv with modern CT scanners and prospective ECG gating mean radiation exposure from pre-procedural CT may be less of a concern with contemporary equipment. 10 
Post-procedural imaging
CT is routinely used following pulmonary vein isolation for assessing for procedural complications. Oesophageal injury and pulmonary vein stenosis are two complications that the radiologist should be familiar with. Oesophagitis and atrio-oesophageal fistulae can arise following ablation of the posterior left atrial wall as the oesophagus descends in the posterior mediastinum and is often separated from the posterior wall of the LA by a thin fat pad ( Figure 5 ). In 90% of subjects the oesophagus courses adjacent to the left pulmonary veins separated from the LSPV by a mean distance of 10 mm and from the LIPV by only 3 mm.
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CT findings of oesophageal injury are similar to those of mediastinitis centred on the posterior aspect of the LA and may feature stranding of the mediastinal fat, localised gas locules or fluid collections. Gas within the LA confirms the presence of an atrio-oesophageal fistula.
Pulmonary vein stenosis is another potential complication that can result from ablating too close to or within the pulmonary vein ostia ( Figure 6 ). An incidence of 0.29% is reported, and when severe can cause complete occlusion of the vein with subsequent venous infarction and pulmonary hypertension. 7 CT can readily identify the location, length and degree of stenosis and can compare the appearances to those on pre-procedural images, although care should be taken to ensure the images are acquired at the same point of the cardiac cycle as the ostial diameter may vary by up to 32%.
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Measurements in the double oblique plane are advocated for both accuracy and reproducibility.
Other findings on CT in support of the diagnosis include stranding and infiltration of the adjacent mediastinal fat, reactive lymphadenopathy, localised septal thickening, and peripheral pulmonary opacities suggestive of venous infarction.
LAA occlusion
There are many patients with AF in whom anticoagulation is contraindicated or who continue to have embolic events despite anticoagulant therapy. An alternative treatment strategy in such patients is percutaneous device-based occlusion of the LAA, from where 90% of thrombi are thought to originate. 13 Pre-procedural imaging Table 2 summarises the applications of CT in LAA occlusion. The main goals of pre-procedural imaging are to assess the size and morphology of the LAA and to evaluate for thrombus within the LAA.
The LAA is a finger-like projection arising from the LA and projecting in an antero-superior direction towards the pulmonary trunk and the proximal left anterior descending and circumflex arteries ( Figure 7) . For the purposes of device-based closure, four morphologies are described: (i) multilobed with an obvious bend (chicken wing morphology), (ii) single lobed without a bend (windsock morphology), (iii) multilobed without an obvious bend or dominant lobe (cauliflower morphology), or (iv) multilobed without an obvious bend but with a dominant lobe (cactus morphology).
14 The dimensions of the dominant lobe should be described to assist with device selection. The presence of thrombus in the LAA is identified by a lowattenuation filling defect and is an absolute contraindication to LAA closure ( Figure 8) . Although transoesophageal echocardiography (TOE) is the gold standard, CT has an excellent negative predictive value (98%). 15 Hence, if the LAA opacifies completely on the initial phase then a thrombus can be confidently excluded. However, if a thrombus is suspected based on an apparent filling defect, a confirmatory delayed phase (40-60 s) can be performed to distinguish between a genuine thrombus and a pseudothrombus (due to poor filling of the LAA with contrast secondary to venous stasis and/or poor left atrial function) ( Figure 9 ). Only genuine thrombus will be seen as a persistent filling defect on the delayed phase. This delayed phase obviously comes with additional radiation exposure. To address this, an alternative split-bolus protocol for contrast administration has been described consisting of an initial 50 mL bolus followed by a second 70 mL bolus 180 s later. Excellent sensitivity and specificity values have been reported with this protocol, however, it requires a higher dose of contrast material and may not be suitable for patients with renal impairment. 16 More recently, dual energy CT which makes use of both high and low kV sources to estimate the iodine density in a ROI, has been described and early experience suggests that it is highly sensitive and specific for differentiating thrombus from venous stasis. 17 
Post-procedural imaging
TOE is routinely performed following LAA occlusion, however, CT can also confirm correct position of the device, assess for adherent thrombus, and to evaluate for leakage around the device and into LAA. The presence of a peri-device gap of <3 mm ± 2 mm is generally considered acceptable and not thought to confer an addition risk of stroke. 18 
Device implantation
Pre-procedural imaging Table 3 outlines the applications of CT in cardiac device implantation. Patients with heart failure or advanced cardiomyopathy often undergo device implantation, either in the form of an implantable cardioverter defibrillator in those at risk of sudden cardiac death, or cardiac resynchronisation therapy (CRT) in those with evidence of ventricular dyssynchrony on ECG. Pre-procedural imaging can assist in lead placement by visualisation of the coronary venous anatomy and by detecting the presence of myocardial scar. In cases of CRT, imaging may also be of value in patient selection by demonstrating mechanical dyssynchrony.
When positioning a left ventricular pacing wire, the coronary sinus is accessed via the right atrium and the wire advanced to a cardiac vein overlying the postero-lateral wall of the left ventricle. This area of myocardium is often the last to activate and thus placing the wire here typically produces optimal haemodynamic results. Traditional methods of visualising the coronary venous anatomy include delayed phase imaging during coronary angiography, and directly cannulating By incorporating an additional 4 s delay into the standard CT coronary angiography protocol, the coronary sinus and veins are usually well opacified. Nitroglycerin is not required unless the coronary arteries are also being examined. Information such as the size, angle and location of the coronary sinus, the position, and branching pattern of the coronary veins as well as identifying the presence of prominent Thebesian valves can assist the operator with opitmal lead placement ( Figure 10) .
Myocardial scar in the region of the tip of the pacing wire may impair electrical conduction and contribute to a poor therapeutic response. MRI is the current gold standard in the detection of myocardial scar, however CT can also visualize the location and extent of scar and correlates well with MRI. 19 Iodine-based contrast material has similar properties to gadolinium and demonstrates areas of fibrosis through late enhancement, usually on 15 min delayed phase images ( Figure 11 ). Table 4 summarises the relative advantages and disadvantages of CT and MRI prior to device implantation, pulmonary vein ablation, and LAA occlusion. Mechanical dyssynchrony is commonly assessed by echocardiography, however, CT, MRI, and radionuclide imaging offer viable alternatives. CT has the potential to quantify mechanical dyssynchrony based on either the time to maximal wall thickness or the time to minimum ventricular volume. Early studies suggest that CT may be more reproducible and quicker than echocardiography. 25, 26 Post-procedural imaging CT is occasionally used as an adjunct to echocardiography and radiography to determine lead position and evaluate for complications such as pacing lead perforation, however, artefact can often interfere with image interpretation. Metal artefacts are related to the density of the metal itself as well as the interface between the metal and the less dense tissue. This results in the characteristic streak artefact of alternating bright and dark streaks.
Moreover, partial volume effects can also make the precise location of the lead tip difficult to ascertain, and can give the erroneous impression of lead perforation. In such cases the lead often appears to protrude through the myocardium by 1-2 mm. Caution is advised in interpreting such images, especially when secondary signs of perforation such as pericardial effusion are absent.
The streak artefact may be reduced by increasing the tube voltage, thereby producing a more mono-energetic beam at a cost of increased radiation exposure. Partial volume effect can be minimized by decreasing the collimation or by using a sharp reconstruction kernel to increase the spatial resolution. In addition, iterative reconstruction metal artefact reduction algorithms are now available to reduce metal artefacts. 
Conclusion
Cardiac CT has evolved into a practical and valuable imaging modality and is being increasingly used in EP intervention. Prior to the procedure, it can be used to evaluate for contraindications, depict the anatomy and assist in guiding the procedure. Following the procedure it can be used to monitor for complications. An awareness of the applications of CT can assist the radiologist in making such procedures quicker, safer, and more effective. 
